Comprehensive Clinical Development Names Christopher Ore as Sr. Vice President and General Manager, Early Phase Clinical Research
Comprehensive Clinical Development, a strategic clinical research company providing a broad range of clinical services from Phase l through lll clinical trials, today announced that Christopher Ore has been appointed as Sr. Vice President and General Manager, Early Phase Clinical Research.
“Chris has extensive experience in early phase clinical research and strategic business development,” stated Jack McGovern, CEO. “Having a leader of Chris’s caliber on our management team will continue to strengthen Comprehensive’s early phase clinical service capabilities. In addition to spearheading business development, he will play a key role in streamlining our operations, leveraging recent lean initiatives company-wide and underscoring the Company’s mantra of Confidence in Comprehensive.”
Mr. Ore has more than 25 years of clinical research experience, including managing early phase clinical/bioanalytical operations in Canada and the United States and as a founding partner at LAB Pharmacological and PharmaResearch. Prior to joining Comprehensive, Mr. Ore served as Vice President and General Manager of Biovail Contract Research Division and as Executive Director Clinical Pharmacology, North America with Covance.
About Comprehensive Clinical Development
Comprehensive Clinical Development is a strategic clinical research partner providing a full range of clinical services in a broad range of therapeutic areas. Comprehensive maintains an outstanding record for consistently delivering quality and success on time and within budget. As a leader in the field of Phase I clinical pharmacology, Comprehensive holds a solid track record of collecting early safety and efficacy data across both healthy and specialty populations and offers distinct capabilities in clinical research.
For more information about Comprehensive, visit www.ComprehensiveCD.com.
Contact: Anne Dubin